Induced sputum nitrites correlate with FEV1 in children with cystic fibrosis

被引:6
|
作者
Anil, N. [1 ]
Singh, M. [2 ]
Rajwanshi, A. [3 ]
Vohra, H. [1 ]
机构
[1] Postgrad Inst Med Educ & Res, Dept Expt Med & Biotechnol, Sector 12, Chandigarh 160012, India
[2] Postgrad Inst Med Educ & Res, Dept Pediat, Chandigarh 160012, India
[3] Postgrad Inst Med Educ & Res, Dept Cytol & Gynaepathol, Chandigarh 160012, India
关键词
Cystic fibrosis; Induced sputum; Lung function; Nitrites; PULMONARY-FUNCTION; LUNG-DISEASE; OXIDE GAS; AIRWAYS; BRONCHIECTASIS; INFLAMMATION; METABOLITES; NITRATE;
D O I
10.1111/j.1651-2227.2010.01682.x
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Aim: To determine the difference in the levels of nitrites in induced sputum of children with cystic fibrosis (CF) and controls. Furthermore, to evaluate the association between induced sputum nitrites and lung function in children with CF. Methods: Nitrites, cell differentials, white blood cell count, were estimated in induced sputum of 20 children with CF and 10 age-matched healthy controls. Nitrites in induced sputum samples were measured using the Greiss assay. Lung function was ascertained by spirometry. Results: We observed high levels of nitrites in CF (184.8 +/- 11.07 mu M/L) versus controls (56.4 +/- 5.7 mu M/L) (p < 0.01). A positive correlation between neturophil percent and nitrites, white blood cell count and nitrites (p < 0.05) in children with CF was observed. Sputum nitrites correlated negatively with FEV1 (p < 0.05) in children with CF. Conclusion: Induced sputum nitrite could serve as a useful non invasive marker for assessing the degree of inflammation in the airways of children with CF.
引用
收藏
页码:711 / 714
页数:4
相关论文
共 50 条
  • [21] Rhinovirus-associated pulmonary exacerbations show a lack of FEV1 improvement in children with cystic fibrosis
    Cousin, Mathias
    Molinari, Nicolas
    Foulongne, Vincent
    Caimmi, Davide
    Vachier, Isabelle
    Abely, Michel
    Chiron, Raphael
    INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2016, 10 (02) : 109 - 112
  • [22] Year to year change in FEV1 in patients with cystic fibrosis and different-mutation classes
    De Boeck, K.
    Zolin, A.
    JOURNAL OF CYSTIC FIBROSIS, 2017, 16 (02) : 239 - 245
  • [23] Routine spirometry in cystic fibrosis patients: impact on pulmonary exacerbation diagnosis and FEV1 decline
    Barboza de Aquino, Carolina Silva
    Rodrigues, Joaquim Carlos
    Ferreira da Silva-Filho, Luiz Vicente Ribeiro
    JORNAL BRASILEIRO DE PNEUMOLOGIA, 2022, 48 (03)
  • [24] FEV1 as a guide to lung transplant referral in young patients with cystic fibrosis
    Robinson, W
    Waltz, DA
    PEDIATRIC PULMONOLOGY, 2000, 30 (03) : 198 - 202
  • [25] Reference percentiles of FEV1 for the Canadian cystic fibrosis population: comparisons across time and countries
    Kim, Sang-Ook
    Corey, Mary
    Stephenson, Anne L.
    Strug, Lisa J.
    THORAX, 2018, 73 (05) : 446 - 450
  • [26] Clinical Use of Dornase Alfa Is Associated With a Slower Rate of FEV1 Decline in Cystic Fibrosis
    Konstan, Michael W.
    Wagener, Jeffrey S.
    Pasta, David J.
    Millar, Stefanie J.
    Jacobs, Joan R.
    Yegin, Ashley
    Morgan, Wayne J.
    PEDIATRIC PULMONOLOGY, 2011, 46 (06) : 545 - 553
  • [27] Effect of supervised training on FEV1 in cystic fibrosis: A randomised controlled trial
    Kriemler, Susi
    Kieser, Stephanie
    Junge, Sibylle
    Ballmann, Manfred
    Hebestreit, Alexandra
    Schindler, Christian
    Stuessi, Christoph
    Hebestreit, Helge
    JOURNAL OF CYSTIC FIBROSIS, 2013, 12 (06) : 714 - 720
  • [28] The predictive role of lung clearance index on FEV1 decline in cystic fibrosis
    Ozsezen, Beste
    Yalcin, Ebru
    Emiralioglu, Nagehan
    Unlu, Hande Konsuk
    Tural, Dilber Ademhan
    Caka, Canan
    Sunman, Birce
    Dogru, Deniz
    Ozcelik, Ugur
    Kiper, Nural
    TURKISH JOURNAL OF PEDIATRICS, 2024, 66 (03) : 297 - 308
  • [29] The lung microbiota in children with cystic fibrosis captured by induced sputum sampling
    Weiser, Rebecca
    Oakley, Juliette
    Ronchetti, Katherine
    Tame, Jo-Dee
    Hoehn, Sven
    Jurkowski, Tomasz P.
    Mahenthiralingam, Eshwar
    Forton, Julian T.
    JOURNAL OF CYSTIC FIBROSIS, 2022, 21 (06) : 1006 - 1012
  • [30] Cystic fibrosis patients at risk for disease progression marked by decline in FEV1% predicted: development of the cystic fibrosis risk of disease progression score
    Marsteller, Nathan L.
    Nussbaum, Eliezer
    Morphew, Tricia
    Randhawa, Inderpal S.
    JOURNAL OF THORACIC DISEASE, 2019, 11 (12) : 5557 - 5565